MyMD Pharmaceuticals Reports Statistically Significant Positive Topline Phase 2 Results for Next Generation Oral TNF- Inhibitor MYMD-1 in SarcopeniaAge-Related Frailty
| MYMDDelisted Stock | USD 1.82 0.02 1.09% |
About 61% of MYMD Old's investor base is looking to short. The analysis of current outlook of investing in MYMD Old suggests that many traders are alarmed regarding MYMD Old's prospects. The current market sentiment, together with MYMD Old's historical and current headlines, can help investors time the market. In addition, many technical investors use MYMD Old stock news signals to limit their universe of possible portfolio assets.
MYMD |
MyMD Pharmaceuticals, Inc. , a clinical stage pharmaceutical company committed to developing novel therapies
Read at businesswire.com
 |
MYMD Old Fundamental Analysis
We analyze MYMD Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MYMD Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MYMD Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
MYMD Old is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
MYMD Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MYMD Old stock to make a market-neutral strategy. Peer analysis of MYMD Old could also be used in its relative valuation, which is a method of valuing MYMD Old by comparing valuation metrics with similar companies.
Peers
MYMD Old Related Equities
| UBX | Unity Biotechnology | 34.59 | ||||
| NBY | NovaBay Pharmaceuticals | 9.37 | ||||
| PASG | Passage Bio | 1.52 | ||||
| GOVX | GeoVax Labs | 1.36 | ||||
| KZR | Kezar Life | 1.06 | ||||
| AVIR | Atea Pharmaceuticals | 2.10 | ||||
| KROS | Keros Therapeutics | 2.22 | ||||
| KRON | Kronos Bio | 3.03 | ||||
| LRMR | Larimar Therapeutics | 3.43 | ||||
| LGND | Ligand Pharmaceuticals | 3.89 | ||||
| REPL | Replimune | 4.08 | ||||
| RXRX | Recursion Pharmaceuticals | 5.23 | ||||
| BOLT | Bolt Biotherapeutics | 5.26 | ||||
| XBIO | Xenetic Biosciences | 5.39 | ||||
| NVCT | Nuvectis Pharma | 5.83 | ||||
| ORIC | Oric Pharmaceuticals | 6.35 | ||||
| GOSS | Gossamer Bio | 7.62 | ||||
| LYEL | Lyell Immunopharma | 7.69 | ||||
| REVB | Revelation Biosciences | 8.62 | ||||
| LYRA | Lyra Therapeutics | 9.09 | ||||
| DSGN | Design Therapeutics | 11.02 | ||||
| SRZN | Surrozen | 12.96 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in MYMD Stock
If you are still planning to invest in MYMD Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MYMD Old's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |